Candorium Free Members
Join Candorium to access the full article and more
Free Member Benefits:
✔
Comment & Reply✔
Newsletter Access✔
Follow Authors✔
Share via SMS Go Back
PIERIS PHARMACEUTICALS, INC. reports $13.2 million Q1 loss
By USInMinutes - May 10, 2023, 10:19 AM ET
Last Updated - Jul 18, 2023, 03:31 PM EDT
The company generated $1.90 million in quarterly revenue
PIERIS PHARMACEUTICALS, INC. [PIRS] has reported fiscal Q1 loss of $13.20 million.
On a per-share basis, the NV based company said its diluted earnings are $0.18.
The Pharmaceutical Preparations firm posted revenue of $1.90 million in this period.
Also Read:
- Pieris Pharmaceuticals to Host First Quarter 2023 Investor Call and Provide Corporate Update on May 10, 2023
- Pieris Pharmaceuticals to Host First Quarter 2023 Investor Call and Provide Corporate Update on May 10, 2023
- Pieris Pharmaceuticals to Host Year End 2022 Investor Call and Provide Corporate Update on March 29, 2023
- Pieris Pharmaceuticals To Present at Evercore ISI Healthconx Conference
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News